European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015-Short version - EDF in cooperation with EADV and IPC
Abstrakt
This is an executive summary of all consented recommendations of the European Psoriasis Guidelines - Update 2015. The long version of this guideline is available online as supplementary file.
A detailed description of the used methodology can be found in the methods report (DOI: 10.1111/jdv.13353). In brief, available evidence of the efficacy and safety of the systemic treatments for psoriasis including an assessment of the quality of evidence was summarized using GRADE (Grading of Recommendations Assessment, Development and Evaluation).1 The end of the literature search was October 12th, 2014.
Some parts of the guidelines are based on a complete literature review (marked as evidence based), other parts are based on expert consensus only (marked as expert opinion). All recommendations (highlighted in grey) were formulated and consented by an expert panel, officially nominated by the European Dermatology Forum (EDF), the European Association for Dermatology and Venereology (EADV) or the International Psoriasis Council (IPC).